B
abesiosis is a zoonotic infection caused by the tickborne intraerythrocytic protozoan parasite Babesia. 1 In the United States, human babesiosis is attributed primarily to infection with B. microti, which is endemic to portions of the Northeast and upper Midwest. [2] [3] [4] [5] Seven states have historically been considered endemic: Connecticut, Rhode Island, New York, Massachusetts, New Jersey, Minnesota, and Wisconsin. In addition, we consider Maine and New Hampshire endemic based on recent published literature and Pennsylvania has seen increasing incidence and some endemic foci. [6] [7] [8] [9] [10] Distribution is variable; endemic states have hyperendemic foci and areas at much lower risk. Babesiosis can also be caused by other Babesia species, such as B. duncani on the West Coast of the United States.
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B. microti is usually transmitted to humans, as an incidental host, by the black-legged tick, Ixodes scapularis. The organism is maintained naturally through an enzootic reservoir, primarily the white-footed mouse (Peromyscus leucopus), while deer can nourish and transport adult ticks to expanding geographic areas. 15, 16 Tick larvae acquire the ABBREVIATIONS: ERI(s) 5 entomologic risk index(-es);
IFA 5 indirect fluorescent antibody; TTB 5 transfusiontransmitted babesiosis. organism via a blood meal from an infected rodent host and continue to carry the parasite as they develop into nymphs (approximately the size of a poppy seed), the stage most likely to transmit the organism to humans. In addition to tickborne transmission, B. microti may be transmitted by blood transfusion from asymptomatic blood donors. 17 Vertical transmission has also been reported rarely. 18 The parasite invades red blood cells (RBCs), resulting in an infection that can range from asymptomatic to severe disease. Symptomatic disease presents most commonly with fever, chills, malaise, myalgia, gastrointestinal symptoms, and/or hemolytic anemia. 19 Fulminant disease can manifest with disseminated intravascular coagulation, hemodynamic instability, and potentially fatal multiorgan dysfunction. 19 The 
Case criteria and classification
We used the following case criteria to determine Babesia infection in patients: diagnosed Babesia infection confirmed by laboratory testing. Parasitologic evidence included observation of Babesia organisms on peripheral blood smear or detection of Babesia DNA by a molecular method. Serologic evidence included positive results (titer 256) by indirect fluorescent antibody (IFA) or immunoglobin G (IgG) immunoblot. Additional criteria for TTB were: 1) receipt of a blood component within a plausible time frame and 2) absence of evidence that another route was more likely than transfusion. A TTB case was considered definite if an extant segment demonstrated evidence of infection. A TTB case was considered probable if linked, in a plausible time frame, to a donor found positive by nucleic acid testing or a titer of 64 or more on serologic testing on a specimen collected subsequently. A TTB case was considered possible if no donor was implicated, but it was not possible to test all donors, and the patient had no other plausible risk. If all associated donors were seronegative or the patient's infection predated any transfusion(s), the case was excluded as transfusion transmitted. Cases not linked to transfusion or transplantation were considered community acquired.
Tick surveillance
Host-seeking I. scapularis ticks were collected using standardized drag surveys, conducted during peak tick activity periods in New York (May-July and October-December) as described. 20 Sites included publicly accessible lands across New York, primarily parks and nature preserves, considered to be at high risk of human exposure to B. microti due to the presence of suitable tick and small mammal habitat and recreational trails. After species confirmation, individual I. scapularis ticks were homogenized and tested for B. microti DNA by polymerase chain reaction (PCR). 25 
Data collection and analysis
Data on community-acquired cases, including geographic location, were obtained through investigation of reported cases of the disease and laboratory reporting of positive test results indicative of infection. The cases determined to be confirmed were enumerated, characterized, and stratified by county of patient residence for each year. The four highest-incidence counties were identified for further analysis. The community-acquired group was stratified by age and sex. For each reported potential TTB case, we obtained and evaluated the recipient's clinical history and course, including outcome, and laboratory test results, including consideration of date(s) of pertinent transfusion(s) and type(s) of component(s) received. After identification of potentially implicated transfusion(s), we determined whether any extant segment(s) from pertinent unit(s) were available for testing, along with any possible extant cocomponents in storage or units donated subsequently by a suspect donor. If no other sample was available, suspect donors were contacted and asked to provide a new sample for testing. Testing, performed or confirmed at the state public health laboratory, included IFA and PCR. When an implicated unit and donor were identified, the following data were determined and recorded in a database: 1) date of implicated donation, 2) type of component transfused, 3) interval between donation and transfusion, 4) interval between transfusion and development of recipient symptoms, and 5) implicated donor demographics, including the counties of residence and of donation. In our analysis, we considered cases in which transfusion transmission was excluded and those that met only possible criteria not to be transfusion transmitted. We stratified the implicated donor group by age and sex.
Ticks testing positive for B. microti were enumerated by county of collection. We calculated county-level prevalence rates by determining the mean percentage of ticks infected with B. microti. Tick density was summarized as the mean number of nymphs collected per man-hour at the site and county levels. Site-and county-level entomologic risk indexes (ERIs) were calculated as a product of nymphal tick density and B. microti prevalence in hostseeking nymphs, as described. 26 
Statistical analysis
We calculated incidence rates as the number of babesiosis cases per 100,000 population per year. We employed linear regression to analyze trends over time. Sex differences between TTB patients and donors were compared using chi-square comparisons with Bonferroni adjustment. Spearman correlation tests were used to explore the relationship between ERI and incidence of babesiosis at the county level. Data analyses were performed using computer software (SAS, v9.4 SAS Institute, Inc.). A p value of less than 0.05 was considered significant in this analysis. Incidence rates and pathogen prevalence in host-seeking nymphal ticks were mapped using computer software (ArcGIS, Version 10.4, ESRI). Of the 55 TTB cases included in the analysis, four met the criteria for definite TTB based on testing of an extant segment. One segment was positive by PCR; the other three were positive by IFA, with titers of 1024, 1024, and 256, respectively. The other 51 cases met criteria as probable TTB. In addition, 10 reported potential cases were excluded as TTB (most frequently when a retrospective review of blood smears demonstrated B. microti parasites before any transfusion) and 26 cases meeting only the definition of possible TTB were identified. These 36 were not included in the analysis of TTB cases, but were included in "all" cases.
In 54 TTB cases, the implicated component was RBCs; in the other case, a unit of frozen deglycerolized RBCs was implicated. There were two clusters; in each, blood collected from the same donor on two different occasions resulted in infection in two recipients. In one cluster, 2 units of RBCs donated by a single donor, 56 days apart, were each implicated in transmission of Babesia to a (different) recipient. In the other cluster, 2 units of RBCs donated 69 days apart were each implicated in transmission to a (different) recipient. The mean observed incubation period from date of implicated transfusion to onset of symptoms was 35.9 days (median, 34 days; range, 8-91 days). The mean maximum parasitemia, when known, in TTB cases was 6.1% (median, 5%; range, 0.01%-29%).
For both all cases and TTB cases, the patient age and sex distributions are shown in Table 1 . TTB cases accounted for 9.2% of cases among children up to age 19, and 31% of all patients less than 5 years of age. While there was an even distribution of TTB cases across the sexes (49% male, 51% female), the distribution of all reported babesiosis cases was more heavily skewed toward males (62% male, 38% female). Although the difference was not significant (v 2 5 3.8213, p 5 0.0506), it is meaningful in that it highlights the difference between the sex distribution of TTB versus all cases. The implicated donors in the TTB cases were more likely to be male (84% male, 16% female), compared to the overall donor population, which is more evenly split between the sexes (57% male, 43% female). Comparison of the sex distribution of the three groups specific to this study, TTB cases, community-acquired babesiosis cases, and implicated donors, showed a significant difference (v 2 5 14.77, p 5 0.0006). Figure 3 shows all implicated donations for years 2004 to 2015 stratified by month of donation. Month of implicated donation was relatively evenly distributed over the 12 years studied (data not shown). A large proportion (27/55, 49%) of implicated donations took place in July, August, or September, consistent with exposure occurring during the known peak nymphal I. scapularis tick activity from mid-May through mid-August. 6 In contrast, little activity was seen in March and April, providing only two (4%) of the total implicated donations over the 12-year study interval. However, it is important to note that at least one implicated donation took place in each month of the year. Entomologic risk index is a measure of tickborne disease risk: the product of tick abundance and pathogen prevalence in host-seeking ticks from a given location. Babesiosis incidence rates per 100,000 population and B. microti ERI, by New York county, for years 2004, 2008, 2012 , and 2015 are shown in Fig. 4 . The increase in incidence across the counties in the Downstate and Lower-to Mid-Hudson Valley regions can be seen in the time progression displayed, with a corresponding increase in B. microti ERI. Three counties-Columbia, Dutchess, and Suffolk-saw significant increases in incidence over the 12-year study period ( and Westchester County's incidence increased from 1.0 to 5.8 cases per 100,000 population during this period, although this increase was not statistically significant. New York State also saw a significant increase from prevalence rates of B. microti in host-seeking nymphs and human babesiosis incidence (r 5 0.57, p < 0.0001), and 3) B. microti ERI and human babesiosis incidence (r 5 0.58, p < 0.0001; Table 2 ). All implicated donors resided in the northeastern region of the United States, with a majority (55%) residing within one of the four known highest-incidence counties (of 62) in New York (Suffolk, Westchester, Dutchess, and Columbia Counties). In addition, one upstate donor had traveled to Connecticut, seven implicated units were collected in New Jersey, and blood units imported from outof-state blood centers had been collected in Massachusetts (3), Rhode Island (1), or Pennsylvania (1).
All except two (5%) of the reported TTB patients had at least one established risk factor for symptomatic babesiosis among their age or underlying comorbidity(-ies). Although more than half (28/55, 51%) of affected recipients were either 60 years of age or older (26, 48%) or less than 1 year of age (two, 4%), the most notable risk factor was asplenia (17/55, 32%). Of the 17 patients who had undergone splenectomy, 11 (65%) had a hemoglobinopathy (b-thalassemia or sickle cell disease). In addition, two spleen-intact patients had sickle cell disease, in which functional hyposplenism is common. 27 Other identified risk factors included treatment for a malignancy or other immunosuppression (11, 20%) , and history of hematopoietic progenitor cell or solid organ transplant (two and three patients, respectively). One patient (2%) had three risk factors, eight (15%) had two risk factors, and 44 (80%) had one risk factor. The two cases (4%) not linked to a recognized risk factor included a 58-year-old with liver disease and a 50-year-old with iron deficiency anemia. Two patients (4%) died of Babesia infection in the context of their underlying comorbidities: a woman in her 90s with gastrointestinal bleeding and a man in his 60s status posthip surgery complicated by infection. [Color figure can be viewed at wileyonlinelibrary.com] Temporal and geographic changes in the incidence of community-acquired babesiosis and TTB, as well as tick activity, demonstrated oscillations between years. For example, 2012 was a low year for both tick activity and human cases in New York, as well as in the United States. 6 Annual fluctuations in human babesiosis may be due to fluctuations in I. scapularis density. Field studies have described annual oscillations of I. scapularis nymph populations, attributed to the influence of multiple biotic and abiotic factors. 31, 32 Such temporal fluctuations in tick density have occurred in parallel with fluctuations in annual human Lyme disease incidence, 32, 33 and it is likely that the incidence of babesiosis is also influenced by fluctuations in tick density. An ERI based on the number of I. scapularis ticks infected by Borrelia burgdorferi in a 12-town area of Connecticut correlated highly with the incidence of Lyme disease in the same area. 32 Site-level ERI values have been found to be a significant predictor of the total number of reported cases of babesiosis by municipality. 32 In this study, a strong positive relationship between ERI and human babesiosis incidence rates suggests that the ERI is predictive of human babesiosis risk in New York. ERI appears to be useful for assessing human risk of babesiosis, which could be an important factor in planning interventional strategies to reduce disease risk effectively. The vast majority (95%) of TTB patients identified in this study had at least one identified risk factor for symptomatic disease; in two patients (4%), their Babesia infection proved fatal. The median incubation period from implicated transfusion to development of symptoms was 34 days, consistent with other studies. 17 Limitations of the study include reliance on passive reporting of cases, although three avenues of reporting were in place. Passive reporting relies on a patient being diagnosed with clinical babesiosis, so these numbers do not reflect asymptomatic cases. In addition, collection of host-seeking I. scapularis nymphs overselected sites of possible emerging tick activity from 2008 to 2015, rather than known hyperendemic foci sampled in 2004, and may thus underestimate abundance of infected ticks on a statewide level.
Transfusion-transmitted babesiosis is a serious problem that can result in morbidity and mortality in transfusion recipients. The data herein present a comprehensive longitudinal statewide compilation of reported babesiosis cases and show increasing frequency and geographic expansion, corresponding with an expansion of B. microti-infected ticks, over the 12-year period in a Babesia-endemic state. Blood donor testing in some highly endemic areas has been initiated by some blood collection organizations under investigational product release testing protocols. Efficacy of such screening in reducing the risk of TTB has been demonstrated. 9, 10 However, no licensed test for donor screening is available and investigational testing is not available in all areas. Also, testing cannot be relied on to detect all infectious donations, and temporal and geographic expansion may surpass testing availability. In addition, testing for evidence of B. microti infection may not detect other species of Babesia or other agents, such as Anaplasma phagocytophilum, which is carried by the same tick vector and can result in signs and symptoms very similar to those seen in babesiosis. Public health efforts, including surveillance of community-acquired babesiosis and of tick abundance and infection, may be useful tools in identifying emerging areas of risk that could pose a hazard to transfusion recipients. Establishing communication channels with public health agencies could facilitate blood collection organizations' abilities to tap such resources effectively to inform blood supply safety policies.
